Neonatal blood component therapy.
Blood transfusion therapy plays an important role in the care and management of ill newborns, yet the indications for blood product administration remain controversial. The article reviews basic definitions, indications for blood product transfusion, and risks and difficulties involved in transfusion therapy. Descriptions, indications, ABO/Rh compatibility, shelf life, necessary equipment, dose, rate, and general considerations for various blood product components are included.
D016913:Blood Component Transfusion / Q000009:adverse effects / Q000379:methods* / Q000451:nursing*; D006801:Humans; D007231:Infant, Newborn; D017283:Neonatal Nursing / Q000379:methods*; D010347:Patient Care Planning; D018579:Patient Selection; D012307:Risk Factors